Abiomed, a company that received early-stage small business funding from NIH's National Heart, Lung, and Blood Institute, announced that it will be acquired by Johnson & Johnson. Per the news release, "the transaction broadens Johnson & Johnson MedTech’s (JJMT) position as a growing cardiovascular innovator, advancing the standard of care in one of healthcare’s largest unmet need disease states: heart failure and recovery."

The I-Corps at NIH Program is accepting applications for the first cohort of FY2023 through Wednesday, November 16.

This 8.5-week entrepreneurship training program provides you with practical guidance from experienced industry professionals to help you transition from researcher to entrepreneur on your path towards commercialization.

Past participants have used lessons learned at I-Corps at NIH to write strong Phase II applications, win partnerships and investments, and build a wide network in the field.

Questions? Contact NCI SBIR Program Manager Reema Railkar (reema.railkar@nih.gov) or visit sbir.cancer.gov/icorps.

Diversity Supplement, Contract Proposals Due, I-Corps

The National Institute on Drug Abuse (NIDA) is proud to announce the winners of two prize competitions in translational research:

Cause of Death Elucidated (CODE) in Drug Overdose
Product Prototypes to Combat Drug Craving

Both prize competitions spur innovation in the field of substance use disorder by identifying ideas that may translate into marketable products. If you have questions about the competitions or winners, contact Sara Lioi of NIDA’s Office of Translational Initiatives and Program Innovations.

The NIA Research and Entrepreneurial Development Immersion (REDI) program provides bio-entrepreneurship training to boost the number of university startups and facilitate more diverse career opportunities for early-career scientists working in the fields of aging and aging-related diseases, including Alzheimer’s disease.

REDI-supported trainees will acquire specialized skills for success in areas such as science communications; intellectual property; regulatory affairs; science policy; consulting; drug discovery, approval, and production; and the business of science, science education, and health care. Individuals from diverse backgrounds are encouraged to apply.

Applications are due on Tuesday, November 15.

TABA Needs Assessment, Translational Sciences, NIDA SUD Challenge

The National Institute on Drug Abuse (NIDA) is looking for teams of participants to submit their research ideas that may be used as the foundation for the development of successful new biomedical startups.

The teams must also have a research idea directly related to substance use disorder (SUD) or that could be extended or adapted to be useful for SUD.

Contact: Sara Lioi (NIDAChallenge@nih.gov)

Submissions are due Wednesday, November 16.

Human subjects research, Hispanic innovation, and tech transfer

Two NIH-funded incubator hubs in the NIH Blueprint MedTech program are seeking groundbreaking, collaborative projects to improve the diagnosis and treatment of nervous system disorders.

Proposed neurotechnologies must have a pathway to a prototype for first-in-human testing within four years.

BARDA has partnered with FedTech to launch the Health Security Startup Studio program to commercialize innovative technologies that will prepare us for public health emergencies and health security threats. In this program, extensive portfolio of intellectual property developed with cutting-edge research across the federal and university laboratory networks will be matched with passionate entrepreneurs eager to launch their own venture based on the IP.

Learn more and apply by Sunday, October 16.